Expand PSTV Menu
PSTV MENU

PSTV Latest Press Releases

-- December 4, 2024 --

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium Globe Newswire 7:30 AM

-- December 3, 2024 --

Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply Globe Newswire 7:30 AM

-- November 25, 2024 --

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference Globe Newswire 7:30 AM

-- November 22, 2024 --

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases Globe Newswire 7:30 AM

-- November 21, 2024 --

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases Globe Newswire 7:30 AM

-- November 14, 2024 --

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights Globe Newswire 4:15 PM

-- November 6, 2024 --

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership Globe Newswire 7:30 AM

-- November 5, 2024 --

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024 Globe Newswire 7:30 AM

-- October 29, 2024 --

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas Globe Newswire 7:30 AM

-- October 1, 2024 --

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting Globe Newswire 7:30 AM

-- September 18, 2024 --

Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting Globe Newswire 7:30 AM

-- September 4, 2024 --

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference Globe Newswire 7:30 AM

-- August 14, 2024 --

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights Globe Newswire 4:16 PM

-- August 13, 2024 --

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference Globe Newswire 7:30 AM

-- August 12, 2024 --

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference Globe Newswire 7:30 AM

-- August 8, 2024 --

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024 Globe Newswire 7:30 AM

-- July 25, 2024 --

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference Globe Newswire 7:30 AM